Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 48, 6044-6049, November 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Ngwenya, B. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Ngwenya, B. Z.

Activation of Mouse Macrophages by Alkylglycerols, Inflammation Products of Cancerous Tissues1

Nobuto Yamamoto2, Donald A. St. Claire, Jr., Sadamu Homma and Benjamin Z. Ngwenya

Department of Microbiology and Immunology, Hahnemann University School of Medicine, Philadelphia, Pennsylvania 19102

Alkylglycerols, inflammation products of lipids in cancerous tissues, are potent macrophage stimulating agents. Administration of small amounts (10–100 ng) of alkylglycerols to mice greatly enhanced macrophage activation for Fc-mediated ingestion activity at the 5th day post-treatment. Dose effect analysis revealed that dodecylglycerol (DDG), one of the alkylglycerols, stimulates macrophages most effectively at the dose of 100 ng/mouse. Administration of lower concentrations of a longer carbon chained alkylglycerol, sn-3-octadecylglycerol (batyl alcohol), to mice produced a similar activation of macrophages. In vitro incubation of mouse peritoneal cells with 50 ng DDG/ml efficiently stimulated macrophages for Fc-mediated ingestion activity. However, in vitro treatment of macrophages alone with DDG was unable to stimulate ingestion activity. When a mixture of macrophages and nonadherent (B and T) cells was treated with DDG, a greatly enhanced Fc-mediated ingestion was observed at about 3 h posttreatment, suggesting that nonadherent cells contributed to the activation of macrophages. Since coincubation of these cells with DDG is required for macrophage activation, stepwise stimulation processes by exchanging signaling factor(s) among these cell types were considered for the developmental mechanism of ingestion capacity of macrophages. When a conditioned medium of DDG-treated B- or T-cells was admixed with macrophages and incubated for 3 h, no significantly enhanced ingestion activity of macrophages was observed. Thus, exchange of signaling factor(s) among B- and T-cells was analyzed by transferring conditioned media of DDG-treated B- or T-cells to untreated T- or B-cells. When the resultant (treated B-cells->untreated T-cells conditioned medium was admixed with untreated macrophages and incubated for 3 h, a markedly enhanced Fc-mediated ingestion was observed. However, no significant increase in ingestion activity was found in macrophages incubated with the treated T-cell->untreated B-cell conditioned medium. Therefore, we concluded that DDG-treated B-cells initiated macrophage activation processes by releasing and transmitting a signaling factor(s) to T-cells, and in turn the T-cells modified the factor or produced a new factor(s) capable of the ultimate stimulation of macrophages for ingestion capability.

1 This investigation was supported in part by National Science Foundation Grant DMB-8511651 to N.Y.

2 To whom requests for reprints should be addressed, at Department of Microbiology and Immunology, MS 410, Hahneman University, Broad and Vine, Philadelphia, PA 19102.

Received 5/ 4/88. Revised 7/20/88. Accepted 8/ 5/88.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
S. Kanda, Y. Mochizuki, Y. Miyata, H. Kanetake, and N. Yamamoto
Effects of Vitamin D3-Binding Protein-Derived Macrophage Activating Factor (GcMAF) on Angiogenesis
J Natl Cancer Inst, September 4, 2002; 94(17): 1311 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Montrucchio, G. Alloatti, and G. Camussi
Role of Platelet-Activating Factor in Cardiovascular Pathophysiology
Physiol Rev, October 1, 2000; 80(4): 1669 - 1699.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1988 by the American Association for Cancer Research.